Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Berkeley Energia Limited Share Issue/Capital Change 2018

Jul 13, 2018

14839_sha_2018-07-13_1318b068-6d72-4ffd-91d9-28122ab93b2e.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5265U

Berkeley Energia Limited

13 July 2018

BERKELEY ENERGIA LIMITED

NEWS RELEASE  |  13 July 2018  |  LSE: BKY

Dealings to commence

As announced on 29 June 2018, Berkeley Energia Limited (Company) issued 3,650,000 fully paid ordinary shares upon the exercise of 3,650,000 unlisted options.

Application has now been made to the London Stock Exchange for the new ordinary shares, which rank pari passu with the Company's existing issued ordinary shares, to be admitted to trading on the LSE (as depository interests). Dealings will commence on 16 July 2018 (Admission).

The Company's issued ordinary share capital following Admission continues to be 258,334,420 ordinary shares.

The above figure of 258,334,420 ordinary shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company, under the FCA's Disclosure and Transparency Rules.

For further information please contact:

Berkeley Energia Limited +44 20 3903 1930
Paul Atherley, Managing Director and CEO [email protected]
Sean Wade, Chief Commercial Officer
Berenberg (Joint Broker) +44 20 3207 7800
Matthew Armitt
James Brooks
Tamesis Partners (Joint Broker) +44 203 882 2868
Charles Bendon

Richard Greenfield

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

IOEBXLBFVDFEBBV